CTNI-37. EFFICACY OF ONC201 IN PATIENTS WITH ONC201 FOR RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA Article

Arrillaga-Romany, Isabel, Kurz, Sylvia, Tarapore, Rohinton S et al. (2020). CTNI-37. EFFICACY OF ONC201 IN PATIENTS WITH ONC201 FOR RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA . NEURO-ONCOLOGY, 22(Supplement_2), ii50-ii51. 10.1093/neuonc/noaa215.204

cited authors

  • Arrillaga-Romany, Isabel; Kurz, Sylvia; Tarapore, Rohinton S; Sumrall, Ashley; Butowski, Nicholas; Harrison, Rebecca; de Groot, John; Chi, Andrew; Shonka, Nicole; Umemura, Yoshie; Odia, Yazmin; Mehta, Minesh; Nghiemphu, Phioanh; Cloughesy, Timothy; Taylor, Lynne; Graber, Jerome; Kilburn, Lindsay; Dixit, Karan; Lu, Guangrong; Allen, Joshua; Batchelor, Tracy; Lassman, Andrew; Wen, Patrick

authors

publication date

  • November 9, 2020

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Neurosciences
  • Orphan Drug
  • Pediatric
  • Pediatric Cancer
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • ii50

end page

  • ii51

volume

  • 22

issue

  • Supplement_2